Future studies examining PIEZO1 activation and associated signalling in compressed tumour regions or perivascular niches within clinical specimens will be critical to validate the physiological relevance of this mechanism and assess its translational potential in metastatic disease. The gene discussed is PIEZO1; the disease is neoplasm.